MedPath

Video-laryngoscope With a Novel Video-stylet for Difficult Intubation

Not Applicable
Completed
Conditions
Difficult Endotracheal Intubation
Interventions
Device: Control
Device: aScope (Ambu Inc. 6740 Baymeadow Drive Glen Burnie, MD)
Registration Number
NCT01215695
Lead Sponsor
University of Louisville
Brief Summary

We propose to enroll 140 subjects scheduled for elective or urgent/emergent surgery with general anesthesia including endotracheal intubation. Patients qualify for the trial if they are considered a difficult airway case as determined by measurement of common predictive indices for difficult intubation (see inclusion criteria). All patients will be intubated with a GVL. Patients will be randomly assigned to either having their ETT placed with use of a pre-formed stylet provided by the manufacturer of the GVL (control group) or with a flexible, disposable tracheoscope (aScope, Ambu, Denmark) (intervention group). The randomization will be stratified as to whether patients are categorized as predicted difficult airway or have an immobilized cervical spine (C-collar in place).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • BMI > 35
  • Thyromental distance < 6 cm
  • Sterno-mental distance < 12 cm
  • Mallampati grade 3 and 4
  • Interincisor distance < 38 mm
  • Status of dentition: presence of buckteeth
  • Neck movement < 35°
  • Neck circumference >43 cm at the level of the thyroid cartilage
  • Patients with immobilized cervical spine (C-collar in place).
  • History of difficult laryngoscopy or intubation
Exclusion Criteria
  • Full stomach
  • Hiatal hernia
  • Severe GERD (Gastroesophageal reflux disease)
  • Tumors of the upper airway

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlPatients will be randomly assigned to having their ETT placed with use of a pre-formed stylet provided by the manufacturer of the GVL (control group)
InterventionaScope (Ambu Inc. 6740 Baymeadow Drive Glen Burnie, MD)Patients will be randomly assigned to either having their ETT placed with use of flexible, disposable tracheoscope (aScope, Ambu, Denmark) (intervention group).
Primary Outcome Measures
NameTimeMethod
Intubation Time120 seconds

divided into time to successfully place the glidescope (visualization of the epiglottis), time to successfully insert the videostylet (passing through the cords) and time to verified placement of the ETT (as outlined above). Interim bag and mask time, if needed, will not be included in the intubation time. More than 5 attempts or 120 s are regarded as failure of intubation. If failure to secure the airway occurs with the GVL and videostylet, then conventional difficult intubation protocols approved by the University of Louisville Hospital will be implemented.

Secondary Outcome Measures
NameTimeMethod
Laryngeal View Grade of 1 or 230 minutes

The laryngeal view as Grade 1 (full view of the glottis) or Grade 2 (glottis partly exposed, anterior commissure not seen) according to the method described by Cormack and Lehane (1984).

Ease of Intubation2-4 hours after intubation

After completion of the procedure the intubator will be asked to score the ease of intubation. To do this, he/she will give a score from 0-100 with 0 being the easiest and 100 being the hardest.

The Number of Intubation Attempts30 minutes

counted as each approach of the ETT to the glottic entrance.

Neck Movement30 minutes

One observer will video-record the entire intubation procedure. At a later time, an otherwise unrelated observer will watch the video-records and grade the neck movement during intubation. Neck movement will be classified as Grade 0: no neck movement, Grade 1: minimal neck movement, or Grade 2: moderate neck movement. Results are reported as total with mild, moderate, or severe neck movement.

Trial Locations

Locations (1)

University of Louisville Hospital

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath